Advanced MedTech

Advanced MedTech is proud to report record revenues of US$335M for FY2024! This strong performance was driven by our focus on our Integrated Urology Platform (IUP) strategy. Our relentless focus on innovation and our commitment to advancing urology care continue to drive our success, proving the effectiveness of our approach in meeting the evolving needs of the healthcare industry. #GradatimFerociter! More details at: https://lnkd.in/gyGWiyUd

Today we announced that Abel Ang will retire as Group Chief Executive Officer of Advanced MedTech as part of a planned leadership transition. Over the past decade, Abel's leadership has been instrumental in positioning Advanced MedTech as a global leader in urology and medical technology. Under his guidance, the company has achieved remarkable success, including record revenues and numerous innovative product launches. We are excited to share that Yau Chung WONG has assumed the role of Group CEO-designate from 1 July 2024 and will take over as Group CEO on 1 October 2024. Yau Chung has been a vital part of our leadership team since 2013, bringing over 18 years of global experience in healthcare and medical devices. His deep understanding of our business and commitment to innovation make him well-positioned to lead Advanced MedTech into its next phase of growth. We extend our heartfelt thanks to Abel for his outstanding contributions and dedication to our company. We wish him all the best in his future endeavours and look forward to his continued guidance as a member of our Board of Directors. Congratulations to Yau Chung on his new role as Group CEO. We are confident that under his leadership, Advanced MedTech will continue to achieve great success. Read the full press release here: https://lnkd.in/gAp_-Z8b #Leadership #Innovation #Growth #AdvancedMedTech

We're proud to announce that WIKKON’s HK.ESWL-Vm (FPD) is now the first shock wave lithotripter with a Flat Panel Detector (FPD) to receive NMPA approval in China! Equipped with an advanced X-ray localization system and a high-quality amorphous silicon FPD, the HK.ESWL-Vm (FPD) represents a significant upgrade from previous models. It boasts remarkable image quality, a wide dynamic range, and a high frame rate – all within a more compact and lightweight design. This landmark approval reaffirms our commitment to leading through innovation, as we strive to enhance clinical performance and improve patient care.